Bilateral internal thoracic arteries

Abstract

In an attempt to obtain more robust scientific evidence as to whether bilateral internal thoracic artery grafting offers a survival benefit over single internal thoracic artery grafting, the Arterial Revascularisation Trial (ART) enrolled 3102 patients between June 2014 and December 2017 in 28 centres in seven countries. The primary outcome was all-cause mortality at 10 years and the secondary outcome a composite of death, myocardial infarction, and stroke. This chapter describes the implications of the 10-year outcomes of ART.